Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.32 - $0.52 $2,502 - $4,066
-7,821 Reduced 66.59%
3,924 $1,000
Q3 2022

Nov 14, 2022

SELL
$0.43 - $1.56 $13,816 - $50,124
-32,131 Reduced 73.23%
11,745 $5,000
Q2 2022

Aug 11, 2022

SELL
$0.7 - $1.4 $278,415 - $556,830
-397,736 Reduced 90.06%
43,876 $34,000
Q1 2022

May 11, 2022

SELL
$0.63 - $1.59 $31,527 - $79,569
-50,044 Reduced 10.18%
441,612 $571,000
Q4 2021

Feb 10, 2022

SELL
$1.27 - $2.42 $37,287 - $71,051
-29,360 Reduced 5.64%
491,656 $624,000
Q3 2021

Nov 12, 2021

BUY
$2.15 - $3.82 $1.12 Million - $1.99 Million
521,016 New
521,016 $1.14 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.